Articles tagged with 'Lupus' | Hospital for Special Surgery

Hospital for Special Surgery - Archive (Lupus)

2021
September
10,
2021
| 17:37 PM America/New_York
Rheumatology Advisor featuring Mary K. Crow, MD ...
Read more
August
10,
2021
| 12:53 PM America/New_York
AARP Magazine featuring Mary K. Crow, MD ...
Read more
August
06,
2021
| 16:37 PM America/New_York
Becker’s Hospital Review featuring Mary K. Crow, MD ...
Read more
August
02,
2021
| 11:43 AM America/New_York
On August 2, 2021, the US Food and Drug Administration approved the drug anifrolumab (Saphnelo) for the treatment of adult patients with moderate to severe systemic lupus erythematosus (SLE) who are receiving standard therapy. Much of the groundwork ...
Read more
August
02,
2021
| 08:28 AM America/New_York
Philly Voice featuring Mary K. Crow, MD and Kyriakos A. Kirou, MD, DSc, FACP ...
Read more
June
09,
2021
| 18:11 PM America/New_York
RheumatologyConsultant featuring Lisa R. Sammaritano, MD ...
Read more
May
27,
2021
| 18:41 PM America/New_York
RheumatologyConsultant featuring Lisa R. Sammaritano, MD ...
Read more
April
19,
2021
| 13:11 PM America/New_York
RheumNow featuring Mary K. Crow, MD ...
Read more
April
16,
2021
| 07:10 AM America/New_York
Lupus Foundation of America "The Expert Series" podcast featuring Jillian Rose, PhD, MPH, LCSW ...
Read more
April
01,
2021
| 19:15 PM America/New_York
Autumn Years featuring Dee Dee Wu, MD and Priscilla Toral, LCSW ...
Read more
March
31,
2021
| 15:14 PM America/New_York
Lupus Foundation of America featuring Jane E. Salmon, MD ...
Read more
March
17,
2021
| 04:09 AM America/New_York
The Rheumatologist featuring Mary K. Crow, MD ...
Read more
March
17,
2021
| 03:49 AM America/New_York
NBC6 featuring Iris Navarro-Millan, MD ...
Read more
January
29,
2021
| 22:06 PM America/New_York
Rheumatology Advisor “Rheum On Air" podcast featuring Jane E. Salmon, MD ...
Read more
2020
December
03,
2020
| 19:29 PM America/New_York
HSS News featuring Alessandra Pernis, MD ...
Read more
November
18,
2020
| 22:00 PM America/New_York
The Rheumatologist featuring Jane E. Salmon, MD ...
Read more
November
12,
2020
| 21:23 PM America/New_York
The Rheumatologist featuring Mary K. Crow, MD ...
Read more
November
09,
2020
| 10:00 AM America/New_York
At this year’s American College of Rheumatology virtual meeting, Hospital for Special Surgery (HSS) presented exciting research related to rheumatology and orthopedic surgery. The research focuses on the diagnosis of renal disorders, the risk of v...
Read more
November
05,
2020
| 09:14 AM America/New_York
Healio Rheumatology featuring Carol A. Mancuso, MD, FACP ...
Read more
September
29,
2020
| 08:26 AM America/New_York
Patients with systemic lupus erythematosus (SLE) have a 27% higher risk of having a nonfatal cardiovascular disease (CVD) event compared to age- and sex-matched diabetes mellitus (DM) patients and more than twice the risk of the Medicaid general popu...
Read more
September
14,
2020
| 08:12 AM America/New_York
HCP Live featuring Lisa R. Sammaritano, MD ...
Read more
August
05,
2020
| 21:22 PM America/New_York
The Lupus Research Alliance featuring Jane E. Salmon, MD ...
Read more
March
26,
2020
| 08:52 AM America/New_York
Practical Pain Management featuring Lisa R. Sammaritano, MD ...
Read more
March
03,
2020
| 09:53 AM America/New_York
Rheumatology Consultant featuring Jillian Rose, PhD, MPH, LCSW and Priscilla Toral, LCSW ...
Read more
January
17,
2020
| 09:19 AM America/New_York
Lupus News Today featuring Mary K. Crow, MD ...
Read more
2019
December
23,
2019
| 09:54 AM America/New_York
Medscape featuring Jane E. Salmon, MD ...
Read more
December
19,
2019
| 14:05 PM America/New_York
New research provides insight into a proposed mechanism involved in the production of type I interferon (IFN-I) in patients with systemic lupus erythematosus (SLE), according to a perspective in Science authored by Mary K. Crow, MD, physician-in-chie...
Read more
December
19,
2019
| 08:00 AM America/New_York
A successful phase III trial of anifrolumab in systemic lupus erythematosus (SLE), called TULIP-2 (Treatment of Uncontrolled Lupus via the Interferon Pathway–2), reported positive results in this week’s New England Journal of Medicine (NEJM). At p...
Read more